stockrow
Friday 6 November 2026
Export ACB’s income statement to Excel — free account
Aurora Cannabis Inc.
ACB Healthcare Drug Manufacturers Specialty & Generic
Aurora Cannabis Inc.’s revenue for fiscal 2026 (year ended March 2026) was $232.0 million, down 5.95% from fiscal 2025.
- Revenue
- −31.2%
- EPS
- +75.0%
- Free cash flow
- −293.6%
- Total debt
- −82.5%
Quarter to June 2026, against a year earlier
5.23
0.04
+0.77%
Follow ACB
Alert me
Aurora Cannabis Inc. (ACB) P/E ratio
Aurora Cannabis Inc. has no meaningful P/E ratio: its trailing twelve-month earnings is negative. Over the past ten years it has ranged from 0.0× (November 2026) to 1,934× (September 2018) — the current reading is the lowest in ten years.
P/E ratio, daily
Embed this chart
Annual newest first
| Period | P/E ratio | Change |
|---|---|---|
| FY2026 | 0.0× | — |
| FY2025 | 73.4× | — |
| FY2024 | 0.0× | — |
| FY2023 | 0.0× | — |
| FY2022 | 0.0× | — |
| FY2021 | 0.0× | — |
| FY2020 | 0.0× | — |
| FY2019 | 0.0× | — |
| FY2018 | 1,382× | — |
| FY2017 | 0.0× | — |
Quarterly newest first
| Period | P/E ratio | Change |
|---|---|---|
| Jun 2026 | 0.0× | — |
| Mar 2026 | 0.0× | — |
| Dec 2025 | 0.0× | — |
| Sep 2025 | 0.0× | — |
| 37 more quarters | Free account |
Against its own ten years
Low 0.0×
High 1,934×
Ten-year median
0.0×
Current reading's percentile
88
P/E ratio against peers
| Company | P/E ratio |
|---|---|
| EBS Emergent Biosolutions Inc. compare | n/m |
| TKNO Alpha Teknova, Inc. compare | n/m |
| AQST Aquestive Therapeutics, Inc. compare | n/m |
| ACB Aurora Cannabis Inc. | n/m |
| BIOA BioAge Labs, Inc. compare | n/m |
| TLRY Tilray Brands, Inc. compare | n/m |
| ANIK Anika Therapeutics Inc. compare | n/m |
| CGC Canopy Growth Corporation compare | n/m |
| KMDA Kamada Ltd. compare | 18.1× |
| Drug Manufacturers Specialty & Generic industry median | 20.5× |
| Healthcare sector median | 25.2× |
| Market median | 17.9× |
What P/E ratio is
Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.
Stock Price ÷ EPS (Basic) (TTM)